We are international
Donate
TEXT SIZE   


Myeloma Minute
May 12, 2016
05.12.16
May 12, 2016
Share the Minute Facebook Tweet!
Clinical Trials
Donate to the IMF
   

 
This week's question: What is the new Black Swan project called iStopMM?


Multiple Myeloma Bone Study

New ARROW Clinical Trials: Learn How To Participate

New Selinexor STORM Clinical Trials: Learn How To Participate

New Ixazomib Clinical Trials: Learn How To Participate

Join the conversation about myeloma on the Smart Patients Message Board

Upcoming Events

June 18, 2016
Regional Community Workshop

Ann Arbor, Michigan

 

June 25, 2016
Regional Community Workshop

Minneapolis/Edina, Minnesota

August 19-20, 2016
Patient & Family Seminar

Los Angeles, California

 

 

 

 

 

    

x

Spring Edition of Myeloma Today: Stopping Myeloma in Its Tracks...and More

 

The latest issue of Myeloma Today is out with news about an exciting Black Swan Research Initiative study to prevent multiple myeloma before it develops. iStopMM (an acronym for Iceland Stops Treats or Prevents Multiple Myeloma), will examine the blood samples of 140,000 adults over the age of 40 in Iceland. The study will identify the earliest signs of myeloma in these adults, who will then participate in a clinical trial to attempt to stop progression of the disease. Also in this issue, the most promising clinical trials of 2016 and a primer on how the newest myeloma drugs can be used in treatment settings. For a dose of inspiration, check out highlights from Myeloma ACTION Month. To download this issue of Myeloma Today, click HERE.

x

Standing Room Only! Another Successful IMF Symposium at the Oncology Nursing Society Annual Conference


 

Nearly a thousand people attended the IMF-sponsored satellite symposium at the Oncology Nursing Society annual conference in San Antonio, Texas on April 28, 2016. “Updates in Multiple Myeloma: Case Studies in Collaborative Nursing and Patient Care” was presented by a panel that included members of the IMF’s Nurse Leadership Board. Presenters were co-chairs Beth Faiman, PhD, MSN, APRN-BC, AOCN®; and Joseph D. Tariman, PhD, ANP-BC as well as Faculty Donna D. Catamero, ANP-BC, OCN®, CCRC; and Tiffany Richards, RN, MS, ANP-BC. The presentation highlighted myeloma patient case studies and the practice of shared decicion-making between patients, caregivers, and healthcare providers. To download the slides from the presentation, click HERE.

x

Register Now for Webinar on Recent FDA-Approved Myeloma Treatments


 

On May 13th , Dr. Rafat Abonour, Director, Multiple Myeloma Program at Indiana University Simon Cancer Center, and IMF Medical Liaison, will speak about myeloma drugs recently approved by the US Food and Drug Administration (FDA) and their real-world impact in the US. With many of these drugs slated for approval or use in clinical trials around the world, tune into this free webinar to hear about treatments that could soon be available. To learn more about Dr. Abonour and to register, click HERE.

x

High School Senior Organizes a Wiffleball Benefit to Support Myeloma Research


 

Proving that you are never too young to have an impact on cancer research, Connecticut high school senior Mike Tuohy is holding a five-on-five wiffleball fundraiser for his senior project. The proceeds from this event will benefit the International Myeloma Foundation. The Five-on-Five Wiffleball Tournament takes place Saturday, May 14, 2016 at Hotchkiss Field, Route 69, in Prospect, Connecticut. You can create a team of five players, and register them HERE or simply donate to the cause. All proceeds will support myeloma research.

 

 



 

 

 

 


  


Join Our Mailing List

 
                                                                We Would Like to Thank Our Sponsors:
 
Takeda Oncology, Celgene, Amgen, and Bristol-Myers Squibb
 
12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF InfoLine: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe
www.myeloma.org

.

 


 related articles